Photo from archive.org
The Indian pharmaceutical sector is large and has the potential of a global leader for low-priced high-quality drugs. The new patent regulations had a strong impact on the drug industry… Click to show full abstract
The Indian pharmaceutical sector is large and has the potential of a global leader for low-priced high-quality drugs. The new patent regulations had a strong impact on the drug industry in India. There is a serious decline in the number of pharma patents recently after compulsory licensing for drugs was implemented in India. While regulations are meant for reducing the prices of essential drugs, there are investment-related issues when a patent is subjected to voluntary licensing. The present study focuses on three phases in pharmaceutical patenting identified by analysing the major patent databases and the potential shift in pharma patenting sector from acute to lifestyle disease-based drugs. The recent trend identified in the pharma patenting sector in India is quite unusual and unreported so far.
Journal Title: Current Science
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!